<?xml version="1.0" encoding="UTF-8"?><rss version="0.92">
<channel>
	<title>Ataxia Treatment</title>
	<link>http://ataxiatreatment.com</link>
	<description>Adult Stem Cell Technology</description>
	<lastBuildDate>Mon, 03 Oct 2011 19:38:21 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	<!-- generator="WordPress/3.2.1" -->

	<item>
		<title>Researchers closer to understanding stem cell pluripotency</title>
		<description><![CDATA[Recent advances in regenerative medicine show stem cell therapy may ultimately be used to create new blood vessels (angiogenesis), improve heart function and reduce the risk of amputation in patients with peripheral vascular disease. Researchers at University Hospitals (UH) Case Medical Center, however, have developed a novel method to isolate sufficient numbers of autologous endothelial [...]]]></description>
		<link>http://ataxiatreatment.com/researchers-closer-to-understanding-stem-cell-pluripotency/</link>
			</item>
	<item>
		<title>U.S. doctors urge caution on seeking stem cell treatment abroad</title>
		<description><![CDATA[Doctors are cautioning against “seeking experimental treatments in an unregulated environment.” &#8220;We believe that there is merit to this approach, we just want to see it (carried out) well, ethically and rigorously,&#8221; said Dr. Joshua Hare, director of the Interdisciplinary Stem Cell Institute at the University of Miami&#8217;s Miller School of Medicine. Scientists like Hare [...]]]></description>
		<link>http://ataxiatreatment.com/u-s-doctors-urge-caution-on-seeking-stem-cell-treatment-abroad/</link>
			</item>
	<item>
		<title>Scientists using stem cell research to save endangered species</title>
		<description><![CDATA[An Israeli scientist has “led the ground-breaking research team that has produced the first stem cells from endangered species, a breakthrough that could potentially save animals in danger of extinction and bolster endangered species&#8217; health in captivity.” The research was done by Israeli scientist Dr. Inbar Friedrich Ben-Nun at the Scripps Research Institute in California. [...]]]></description>
		<link>http://ataxiatreatment.com/scientists-using-stem-cell-research-to-save-endangered-species/</link>
			</item>
	<item>
		<title>First European stem cell trial approved</title>
		<description><![CDATA[Drug regulators in the United Kingdom have granted approval to Advanced Cell Technology to conduct “the first trial in Europe of human embryonic stem cells, testing the cells in people with a progressive form of blindness,” a U.S. firm said on Thursday. The trial “will test the safety of using replacement retinal cells, which are [...]]]></description>
		<link>http://ataxiatreatment.com/first-european-stem-cell-trial-approved/</link>
			</item>
	<item>
		<title>Stem cell research rebounding after political setbacks</title>
		<description><![CDATA[A “visible and vocal proponent” of human embryonic stem cells (ES), Stephen Minger, says that the number of trials involving human stem cells that are currently on “suggests that the field is emerging from the shadow of skepticism and experimentation.” &#8220;When you see companies like Pfizer, GSK [GlaxoSmithKline], Johnson &#38; Johnson and GE invest in [...]]]></description>
		<link>http://ataxiatreatment.com/stem-cell-research-rebounding-after-political-setbacks-a-sodonh-sci-cp/</link>
			</item>
	<item>
		<title>Unexpected somatic cells potential source for a variety of problems&#8211;including baldness</title>
		<description><![CDATA[Just as with stem cells and various sources for them, researchers are expanding their field of inquiry looking for novel solutions to somatic disorders. “Fat cells in the skin have been identified as the source of chemicals needed to make hair grow,” according to researchers in the US. Experiments on mice, reported in the journal [...]]]></description>
		<link>http://ataxiatreatment.com/unexpected-somatic-cells-potential-source-for-a-variety-of-problems-including-baldness/</link>
			</item>
	<item>
		<title>Cord blood banking firm expanding its medical advisory board</title>
		<description><![CDATA[Americord Registry, a leader in the advancement of cord blood and placenta stem cell preservation, has announced the expansion of its Medical Advisory Board with the appointment of Dr. Eric Adler, who previously served as Interim Medical Director for the company. Dr. Adler will assist with operations related to induced pluripotent stem cell (or iPS [...]]]></description>
		<link>http://ataxiatreatment.com/cord-blood-banking-firm-expanding-its-medical-advisory-board/</link>
			</item>
	<item>
		<title>Umbilical cord blood banking controversial for some, “life insurance” for others</title>
		<description><![CDATA[While “stem cells could be useful in treating various diseases and medical conditions, no cells stored by South African stem cell storage laboratories had been used successfully in treating patients, two experts said last week. This comes after Cryo-Save SA — a joint venture between international Cryo-Save Group and local Lazaron Biotechnologies — last week [...]]]></description>
		<link>http://ataxiatreatment.com/umbilical-cord-blood-banking-controversial-for-some-%e2%80%9clife-insurance%e2%80%9d-for-others/</link>
			</item>
	<item>
		<title>Umbilical cord blood banking expanding in popularity</title>
		<description><![CDATA[Recent research shows a newborn&#8217;s cord blood stem cells can be used to treat dozens of life-threatening diseases.&#8221;Cord blood can be used in place of bone marrow transplants for patients who have blood diseases, like leukemia,&#8221; said Sarah Kuenne, Cord Blood Specialist at the University of Colorado Blood Bank. &#8220;It&#8217;s a process where the blood [...]]]></description>
		<link>http://ataxiatreatment.com/umbilical-cord-blood-banking-expanding-in-popularity/</link>
			</item>
	<item>
		<title>Ataxia-related gene crucial to cancer research</title>
		<description><![CDATA[Cyclacel Pharmaceuticals, Inc. has announced that the first patient has been dosed in an investigator-initiated, translational, Phase 2 clinical study at The University of Texas MD Anderson Cancer Center. The objective of the study is to learn if oral sapacitabine capsules given in combination with two standard injectable drugs, cyclophosphamide and rituximab, or the &#8220;SCR [...]]]></description>
		<link>http://ataxiatreatment.com/ataxia-related-gene-crucial-to-cancer-research/</link>
			</item>
</channel>
</rss>

